delamanid
UkraineDrugs containing this active substance
-
The drug is used as part of combination therapy for the treatment of pulmonary multidrug-resistant tuberculosis (MDR-TB) in adults and children weighing 30 kg or more.
Form: tablets, film-coated
Active substance Dosage delamanid 50 mg ATC: J04AK06
Manufacturer: R-Pharm Germany GmbH (primary packaging, secondary packaging, batch release)